Home > Product > Product Information   
  LEVOMOS TAB. 2.5/20 mg
 
 
 
Essential hypertension in which blood pressure is not adequately controlled by S-amlodipine
 
 
1. Warning
The administration of drugs directly acting on the renin-angiotensin system in pregnant women 2 and 3 can cause damage and death to the fetus and newborn. Therefore, if you are pregnant, you should stop taking this drug immediately. (See section on administration for pregnant women)

2. Do not administer to the following patients
1) Patients with hypersensitivity to the main component and dihydropyridine derivative of NSAID
2) Pregnant and lactating women
3) Patients with severe hepatic impairment
4) Patients with severe aortic stenosis
5) Patients with biliary obstruction
6) Patients with kidney dialysis (no experience)
7) Shock patients
Patients with diabetes and / or moderate to severe renal impairment (glomerular filtration rate <60 mL / min / 1.73 m2) who are taking aliskiren (see section on drug interactions)
9) It should not be given to patients with genetic problems such as galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. Because it contains lactose.